Images gathered by University of Oregon scientists using seismic waves penetrating to a depth of 300 kilometers (almost 200 miles) report the discovery of an anomaly that likely is the volcanic mantle plume of the Galapagos Islands. It's ...
Tags: Consumer Electronics, Electronics
The scent of diesel, rusting anchors and fish slurry hung in the humid air of the harbor. I was in Puntarenas on the western shore of Costa Rica, waiting to leave on a scuba-diving trip to Cocos Island – often called an "underwater ...
Tags: Costa Rica, Agriculture
BP today announced it has added two drilling rigs to the deepwater Gulf of Mexico, bringing its fleet to a company record nine rigs as it continues to develop its strong portfolio of assets in the key U.S. offshore basin. One of the rigs ...
Galapagos and AbbVie have extended their GLPG0634 clinical development collaboration to include Crohn's disease. As per the extension agreement, Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to ...
Tags: AbbVie, Galapagos, Crohn's Disease
US-based biotechnology firm DART Therapeutics is developing a selective androgen receptor modulator (SARM) drug candidate for Duchenne muscular dystrophy (DMD). DMD is a pediatric rare disease that affects approximately one in 3,600 boys ...
Apple sold more phones in Japan than any other manufacturer last year, rising above local manufacturers for the first time, according to a research firm. The report from Counterpoint Research, based in Hong Kong, said Apple had a 15% ...
Tags: Apple, Japan, smart phone
Galapagos has reached a milestone in its immuno-inflammation alliance with GlaxoSmithKline (GSK) by delivering a fifth pre-clinical drug candidate. Galapagos CEO Onno van de Stolpe said the company has identified five candidate drugs of ...
Tags: immuno inflammation, GSK, clinical drug, drug
BioFocus, the Galapagos' service division, and Ono Pharmaceutical have signed a new drug discovery agreement focusing on CNS disorders. BioFocus managing director and Galapagos Services SVP Dr. Chris Newton said, "This project plays to ...
BioFocus and Activiomics have formed a partnership,which will enable BioFocus to offer its customers Activiomics' proteomics services to improve identification of new targets for drug discovery and biomarkers for diagnostics. TIQUAS ...
Galapagos, a mid-size biotechnology company, has delivered the first pre-clinical candidate compound in its osteoarthritis alliance with Servier. Servier and Galapagos entered into an alliance in July 2010 to develop new oral medicines ...
Tags: Galapagos Identifies Drug, Galapagos, Servier, osteoarthritis
Galapagos has identified new class of antibiotics targeting drug resistant Staphylococcus aureus (MRSA) strains and commenced clinical development of first antibiotic. The selected candidate, CAM-1, was effective against all tested MRSA ...
Tags: antibiotics targeting drug, MRSA